Status:
COMPLETED
A Phase II Study of KUC-7483 in Patients With Overactive Bladder
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Conditions:
Overactive Bladder (OAB)
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
To investigate the efficacy and safety of KUC-7483 in overactive bladder patients.
Eligibility Criteria
Inclusion
- Patients with a symptom of overactive bladder for more than 6 months.
- Patients who meet the following condition during the 3-day bladder diary period.
- the mean number of micturitions per 24 hours is ≥8 times
- the mean number of urgency episodes per 24 hours is ≥1 time
Exclusion
- Patients who are diagnosed as stress urinary incontinence are predominant.
- Patients with urinary calculus, interstitial cystitis, or clinically significant urinary tract infection.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00742833
Last Update
September 4 2009
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Japan
Hokkaido Region, Japan
2
Japan
Kansai Region, Japan
3
Japan
Kanto Region, Japan
4
Japan
Kyushu Region, Japan